Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2001, p. 1109-1114, Vol. 45, No. 4
Center for Adaptation Genetics and Drug
Resistance1 and Departments of Molecular
Biology and Microbiology2 and of
Medicine,4 Tufts University School of Medicine,
Boston, Massachusetts 02111, and Laboratory of Food
Microbiology, Institute of Food Science, Department of Agriculture and
Food Science, Eidgenössische Technische Hochschule Zürich,
ETH-Zentrum, CH-8092 Zürich, Switzerland3
Received 8 August 2000/Returned for modification 12 November
2000/Accepted 12 January 2001
The mdt(A) gene, previously designated
mef214, from Lactococcus lactis subsp.
lactis plasmid pK214 encodes a protein [Mdt(A) (multiple
drug transporter)] with 12 putative transmembrane segments (TMS) that
contain typical motifs conserved among the efflux proteins of the major
facilitator superfamily. However, it also has two C-motifs (conserved
in the fifth TMS of the antiporters) and a putative ATP-binding site.
Expression of the cloned mdt(A) gene decreased
susceptibility to macrolides, lincosamides, streptogramins, and
tetracyclines in L. lactis and Escherichia
coli, but not in Enterococcus faecalis or in
Staphylococcus aureus. Glucose-dependent efflux of
erythromycin and tetracycline was demonstrated in L. lactis
and in E. coli.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.4.1109-1114.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mdt(A), a New Efflux Protein Conferring Multiple
Antibiotic Resistance in Lactococcus lactis and
Escherichia coli
*
Corresponding author. Mailing address: Center for
Adaptation Genetics and Drug Resistance, Tufts University School of
Medicine, 136 Harrison Ave., Boston, MA 02111. Phone: (617) 636-6764. Fax: (617) 636-0458. E-mail: stuart.levy{at}tufts.edu.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |